cbdMD (YCBD) Tax Provisions (2016 - 2021)
cbdMD (YCBD) reported Tax Provisions of $765000.0 for Q3 2021, up 185.47% on a YoY basis from $267974.6 in Q3 2020, and up 642.72% sequentially from $103000.0 in Q2 2021.
cbdMD (YCBD) Tax Provisions (2016 - 2021) Analysis & Trends
cbdMD (YCBD) has 6 years of Tax Provisions data on file, last reported at $765000.0 in Q3 2021.
- For the quarter ending Q3 2021, Tax Provisions rose 185.47% year-over-year to $765000.0; the trailing twelve-month figure through Jun 2022 stood at $765000.0 (up 176.81% YoY), and the FY2020 full-year result was $1.3 million, changed N/A from the prior year.
- Tax Provisions advanced to $765000.0 in Q3 2021, from $103000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.3 million in Q3 2019 to a low of -$2.2 million in Q4 2019.
- A 5-year average of -$145488.2 and a median of -$33000.0 in 2017 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 38366.67% in 2019, while the deepest fall reached 4573.91% in 2019.
- Tracing YCBD's Tax Provisions over 5 years: stood at -$33000.0 in 2017, then plunged by 303.03% to -$133000.0 in 2018, then sank by 1584.44% to -$2.2 million in 2019, then soared by 114.82% to $332000.0 in 2020, then soared by 130.42% to $765000.0 in 2021.
- Business Quant data shows YCBD's Tax Provisions at $765000.0 in Q3 2021, $103000.0 in Q2 2021, and -$536000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 765,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Mar 31, 2021 | -536,000.00 |
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | -895,000.00 |
| Dec 31, 2019 | -2.24 Mn |
| Sep 30, 2019 | 2.30 Mn |
| Jun 30, 2019 | -1.09 Mn |
| Mar 31, 2019 | -1.08 Mn |
| Dec 31, 2018 | -133,000.00 |
| Sep 30, 2018 | -6,000.00 |
| Jun 30, 2018 | 62,000.00 |
| Mar 31, 2018 | -23,000.00 |
| Dec 31, 2017 | -33,000.00 |
| Sep 30, 2017 | -42,250.00 |
| Jun 30, 2017 | -36,642.00 |
| Mar 31, 2017 | 76,892.00 |
| Dec 31, 2016 | 2,000.00 |